Your browser doesn't support javascript.
loading
Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer.
Schuettfort, Victor M; Pradere, Benjamin; Trinh, Quoc-Dien; D'Andrea, David; Quhal, Fahad; Mostafaei, Hadi; Laukhtina, Ekaterina; Mori, Keiichiro; Sari Motlagh, Reza; Rink, Michael; Karakiewicz, Pierre I; Chlosta, Piotr; Yuen-Chun Teoh, Jeremy; Lotan, Yair; Scherr, Douglas; Abufaraj, Mohammad; Moschini, Marco; Shariat, Shahrokh F.
Afiliação
  • Schuettfort VM; Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Pradere B; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Trinh QD; Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • D'Andrea D; Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Quhal F; Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Mostafaei H; Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Laukhtina E; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Mori K; Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Sari Motlagh R; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Rink M; Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Karakiewicz PI; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
  • Chlosta P; Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Yuen-Chun Teoh J; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Lotan Y; Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Scherr D; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Abufaraj M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada.
  • Moschini M; Department of Urology, Medical College, Jagiellonian University, Krakow, Poland.
  • Shariat SF; S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Cancer Immunol Immunother ; 71(1): 85-95, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34023914
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Cistectomia / Interleucina-6 / Urotélio / Receptores de Interleucina-6 Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Cistectomia / Interleucina-6 / Urotélio / Receptores de Interleucina-6 Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article